世界のボツリヌス治療市場2020年:企業別・地域別・種類別・用途別市場予測(~2025年)

GlobalInfoResearchが発行した調査報告書(GIR20SP09169)
◆英語タイトル:Global Botulism Treatment Market 2020 by Company, Regions, Type and Application, Forecast to 2025
◆商品コード:GIR20SP09169
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2020年9月23日(※2024年版があります。お問い合わせください。)
◆ページ数:109
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療、製薬、バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートでは、ボツリヌス治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。ボツリヌス治療の種類別市場規模(抗毒素、抗生物質、その他)、用途別市場規模(病院・クリニック、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。
・市場概要
・企業情報(販売量、市場シェア、製品概要、SWOT分析):XOMA (U.S.)、Merz Pharma (Germany)、Morphotek (U.S.)、Microbiotix (U.S.)、Mentor Corporation and Metabiologics (U.S.)、Valeant Pharmaceuticals (Canada)、Galderma (Switzerland)、Lanzhou Institute of Biological Products (China)、Medytox Solutions (U.S.)、Allergan (Irish)
・地域別グローバル市場分析 2015年-2020年
・ボツリヌス治療の北米市場(アメリカ、カナダ、メキシコ)
・ボツリヌス治療のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・ボツリヌス治療のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・ボツリヌス治療の南米市場(ブラジル、アルゼンチン)
・ボツリヌス治療の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:抗毒素、抗生物質、その他
・用途別分析:病院・クリニック、その他
・地域別市場規模予測 2021年-2025年
・調査の結果・結論
【レポートの概要】

Market Overview
The global Botulism Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Botulism Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Botulism Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Botulism Treatment market has been segmented into:
Antitoxin
Antibiotics
Others

By Application, Botulism Treatment has been segmented into:
Hospitals and Clinics
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Botulism Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Botulism Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Botulism Treatment market.

The report offers in-depth assessment of the growth and other aspects of the Botulism Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Botulism Treatment Market Share Analysis
Botulism Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Botulism Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Botulism Treatment sales, revenue and market share for each player covered in this report.

The major players covered in Botulism Treatment are:
XOMA (U.S.)
Merz Pharma (Germany)
Morphotek (U.S.)
Microbiotix (U.S.)
Mentor Corporation and Metabiologics (U.S.)
Valeant Pharmaceuticals (Canada)
Galderma (Switzerland)
Lanzhou Institute of Biological Products (China)
Medytox Solutions (U.S.)
Allergan (Irish)

【レポートの目次】

Table of Contents

1 Botulism Treatment Market Overview
1.1 Product Overview and Scope of Botulism Treatment
1.2 Classification of Botulism Treatment by Type
1.2.1 Global Botulism Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Botulism Treatment Revenue Market Share by Type in 2019
1.2.3 Antitoxin
1.2.4 Antibiotics
1.2.5 Others
1.3 Global Botulism Treatment Market by Application
1.3.1 Overview: Global Botulism Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals and Clinics
1.3.3 Others
1.4 Global Botulism Treatment Market by Regions
1.4.1 Global Botulism Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Botulism Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Botulism Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Botulism Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Botulism Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Botulism Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Botulism Treatment Status and Prospect (2015-2025)
2 Company Profiles
2.1 XOMA (U.S.)
2.1.1 XOMA (U.S.) Details
2.1.2 XOMA (U.S.) Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 XOMA (U.S.) SWOT Analysis
2.1.4 XOMA (U.S.) Product and Services
2.1.5 XOMA (U.S.) Botulism Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 Merz Pharma (Germany)
2.2.1 Merz Pharma (Germany) Details
2.2.2 Merz Pharma (Germany) Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Merz Pharma (Germany) SWOT Analysis
2.2.4 Merz Pharma (Germany) Product and Services
2.2.5 Merz Pharma (Germany) Botulism Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 Morphotek (U.S.)
2.3.1 Morphotek (U.S.) Details
2.3.2 Morphotek (U.S.) Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Morphotek (U.S.) SWOT Analysis
2.3.4 Morphotek (U.S.) Product and Services
2.3.5 Morphotek (U.S.) Botulism Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 Microbiotix (U.S.)
2.4.1 Microbiotix (U.S.) Details
2.4.2 Microbiotix (U.S.) Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Microbiotix (U.S.) SWOT Analysis
2.4.4 Microbiotix (U.S.) Product and Services
2.4.5 Microbiotix (U.S.) Botulism Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 Mentor Corporation and Metabiologics (U.S.)
2.5.1 Mentor Corporation and Metabiologics (U.S.) Details
2.5.2 Mentor Corporation and Metabiologics (U.S.) Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Mentor Corporation and Metabiologics (U.S.) SWOT Analysis
2.5.4 Mentor Corporation and Metabiologics (U.S.) Product and Services
2.5.5 Mentor Corporation and Metabiologics (U.S.) Botulism Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.6 Valeant Pharmaceuticals (Canada)
2.6.1 Valeant Pharmaceuticals (Canada) Details
2.6.2 Valeant Pharmaceuticals (Canada) Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Valeant Pharmaceuticals (Canada) SWOT Analysis
2.6.4 Valeant Pharmaceuticals (Canada) Product and Services
2.6.5 Valeant Pharmaceuticals (Canada) Botulism Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.7 Galderma (Switzerland)
2.7.1 Galderma (Switzerland) Details
2.7.2 Galderma (Switzerland) Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Galderma (Switzerland) SWOT Analysis
2.7.4 Galderma (Switzerland) Product and Services
2.7.5 Galderma (Switzerland) Botulism Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.8 Lanzhou Institute of Biological Products (China)
2.8.1 Lanzhou Institute of Biological Products (China) Details
2.8.2 Lanzhou Institute of Biological Products (China) Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Lanzhou Institute of Biological Products (China) SWOT Analysis
2.8.4 Lanzhou Institute of Biological Products (China) Product and Services
2.8.5 Lanzhou Institute of Biological Products (China) Botulism Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.9 Medytox Solutions (U.S.)
2.9.1 Medytox Solutions (U.S.) Details
2.9.2 Medytox Solutions (U.S.) Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Medytox Solutions (U.S.) SWOT Analysis
2.9.4 Medytox Solutions (U.S.) Product and Services
2.9.5 Medytox Solutions (U.S.) Botulism Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.10 Allergan (Irish)
2.10.1 Allergan (Irish) Details
2.10.2 Allergan (Irish) Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Allergan (Irish) SWOT Analysis
2.10.4 Allergan (Irish) Product and Services
2.10.5 Allergan (Irish) Botulism Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Botulism Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Botulism Treatment Players Market Share
3.2.2 Top 10 Botulism Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Botulism Treatment Revenue and Market Share by Regions
4.2 North America Botulism Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe Botulism Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Botulism Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Botulism Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Botulism Treatment Revenue and Growth Rate (2015-2020)
5 North America Botulism Treatment Revenue by Countries
5.1 North America Botulism Treatment Revenue by Countries (2015-2020)
5.2 USA Botulism Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada Botulism Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico Botulism Treatment Revenue and Growth Rate (2015-2020)
6 Europe Botulism Treatment Revenue by Countries
6.1 Europe Botulism Treatment Revenue by Countries (2015-2020)
6.2 Germany Botulism Treatment Revenue and Growth Rate (2015-2020)
6.3 UK Botulism Treatment Revenue and Growth Rate (2015-2020)
6.4 France Botulism Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia Botulism Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy Botulism Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Botulism Treatment Revenue by Countries
7.1 Asia-Pacific Botulism Treatment Revenue by Countries (2015-2020)
7.2 China Botulism Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan Botulism Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea Botulism Treatment Revenue and Growth Rate (2015-2020)
7.5 India Botulism Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Botulism Treatment Revenue and Growth Rate (2015-2020)
8 South America Botulism Treatment Revenue by Countries
8.1 South America Botulism Treatment Revenue by Countries (2015-2020)
8.2 Brazil Botulism Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina Botulism Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Botulism Treatment by Countries
9.1 Middle East & Africa Botulism Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia Botulism Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE Botulism Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt Botulism Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa Botulism Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Botulism Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global Botulism Treatment Market Forecast by Type (2019-2024)
10.3 Antitoxin Revenue Growth Rate (2015-2025)
10.4 Antibiotics Revenue Growth Rate (2015-2025)
10.5 Others Revenue Growth Rate (2015-2025)
11 Global Botulism Treatment Market Segment by Application
11.1 Global Botulism Treatment Revenue Market Share by Application (2015-2020)
11.2 Botulism Treatment Market Forecast by Application (2019-2024)
11.3 Hospitals and Clinics Revenue Growth (2015-2020)
11.4 Others Revenue Growth (2015-2020)
12 Global Botulism Treatment Market Size Forecast (2021-2025)
12.1 Global Botulism Treatment Market Size Forecast (2021-2025)
12.2 Global Botulism Treatment Market Forecast by Regions (2021-2025)
12.3 North America Botulism Treatment Revenue Market Forecast (2021-2025)
12.4 Europe Botulism Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Botulism Treatment Revenue Market Forecast (2021-2025)
12.6 South America Botulism Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Botulism Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

...

【掲載企業】

XOMA (U.S.)、Merz Pharma (Germany)、Morphotek (U.S.)、Microbiotix (U.S.)、Mentor Corporation and Metabiologics (U.S.)、Valeant Pharmaceuticals (Canada)、Galderma (Switzerland)、Lanzhou Institute of Biological Products (China)、Medytox Solutions (U.S.)、Allergan (Irish)

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のボツリヌス治療市場2020年:企業別・地域別・種類別・用途別市場予測(~2025年)(Global Botulism Treatment Market 2020 by Company, Regions, Type and Application, Forecast to 2025)]についてメールでお問い合わせはこちらでお願いします。